TNF-α and glucocorticoid receptor interaction in L6 muscle cells: A cooperative downregulation of myosin heavy chain

Steroids

Volumn 72, Issue 9-10, 2007, Pages 705-712

  Dekelbab, Bassem H ^a,b   Witchel, Selma F ^a   DeFranco, Donald B ^c  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Glucocorticoid receptor; Myosin heavy chain; TNF

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYOSIN HEAVY CHAIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; GENETIC TRANSCRIPTION; MUSCLE CELL; MYOTUBE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RECEPTOR DOWN REGULATION; SEPSIS;

CELL LINE; DEXAMETHASONE; GENE EXPRESSION REGULATION; HUMANS; MUSCLE CELLS; MYOSIN HEAVY CHAINS; NF-KAPPA B; RECEPTORS, GLUCOCORTICOID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34547174678     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2007.05.007     Document Type: Article

References (35)

1. Bourgeois S., and Newby R.F. Correlation between glucocorticoid receptor and cytolytic response of murine lymphoid cell lines. Cancer Res 39 (1979) 4749-4751
2. Gehring U., Mugele K., and Ulrich J. Cellular receptor levels and glucocorticoid responsiveness of lymphoma cells. Mol Cell Endocrinol 36 (1984) 107-113
3. Vanderbilt J.N., Miesfeld R., Maler B.A., and Yamamoto K.R. Intracellular receptor concentration limits glucocorticoid-dependent enhancer activity. Mol Endocrinol 1 (1987) 68-74
4. Oakley R.H., and Cidlowski J.A. Homologous downregulation of the glucocorticoid receptor: the molecular machinery. Crit Rev Eukaryot Gene Expr 3 (1993) 63-88
5. Burnstein K.L., Jewell C.M., Sar M., and Cidlowski J.A. Intragenic sequences of the human glucocorticoid receptor complementary DNA mediate hormone-inducible receptor messenger RNA down-regulation through multiple mechanisms. Mol Endocrinol 8 (1994) 1764-1773
6. Rosewicz S., McDonald A.R., Maddux B.A., Goldfine I.D., Miesfeld R.L., and Logsdon C.D. Mechanism of glucocorticoid receptor down-regulation by glucocorticoids. J Biol Chem 263 (1988) 2581-2584
7. Dong Y., Poellinger L., Gustafsson J.A., and Okret S. Regulation of glucocorticoid receptor expression: evidence for transcriptional and posttranslational mechanisms. Mol Endocrinol 2 (1988) 1256-1264
8. McIntyre W.R., and Samuels H.H. Triamcinolone acetonide regulates glucocorticoid-receptor levels by decreasing the half-life of the activated nuclear-receptor form. J Biol Chem 260 (1985) 418-427
9. Ali M., Allen H.R., Vedeckis W.V., and Lang C.H. Depletion of rat liver glucocorticoid receptor hormone-binding and its mRNA in sepsis. Life Sci 48 (1991) 603-611
10. Sun X., Fischer D.R., Pritts T.A., Wray C.J., and Hasselgren P.O. Expression and binding activity of the glucocorticoid receptor are upregulated in septic muscle. Am J Physiol Regul Integr Comp Physiol 282 (2002) R509-R518
11. Sun X., Mammen J.M., and Tian X. Sepsis induces the transcription of the glucocorticoid receptor in skeletal muscle cells. Clin Sci (Lond) 105 (2003) 383-391
12. Hasselgren P.O., and Fischer J.E. The ubiquitin-proteasome pathway: review of a novel intracellular mechanism of muscle protein breakdown during sepsis and other catabolic conditions. Ann Surg 225 (1997) 307-316
13. Wang L., Luo G.J., Wang J.J., and Hasselgren P.O. Dexamethasone stimulates proteasome- and calcium-dependent proteolysis in cultured L6 myotubes. Shock 10 (1998) 298-306
14. Tiao G., Hobler S., Wang J.J., Meyer T.A., Luchette F.A., Fischer J.E., et al. Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. J Clin Invest 99 (1997) 163-168
15. Tiao G., Fagan J., Roegner V., Lieberman M., Wang J.J., Fischer J.E., et al. Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids. J Clin Invest 97 (1996) 339-348
16. McKay L.I., and Cidlowski J.A. Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr Rev 20 (1999) 435-459
17. Sen C.K., Khanna S., Reznick A.Z., Roy S., and Packer L. Glutathione regulation of tumor necrosis factor-alpha-induced NF-κB activation in skeletal muscle-derived L6 cells. Biochem Biophys Res Commun 237 (1997) 645-649
18. Acharyya S., Ladner K.J., Nelsen L.L., Damrauer J., Reiser P.J., Swoap S., et al. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest 114 (2004) 370-378
19. Seene T., Kaasik P., Pehme A., Alev K., and Riso E.M. The effect of glucocorticoids on the myosin heavy chain isoforms' turnover in skeletal muscle. J Steroid Biochem Mol Biol 86 (2003) 201-206
20. Hickson R.C., Czerwinski S.M., and Wegrzyn L.E. Glutamine prevents downregulation of myosin heavy chain synthesis and muscle atrophy from glucocorticoids. Am J Physiol 268 (1995) E730-E734
21. Hoeck W., Rusconi S., and Groner B. Down-regulation and phosphorylation of glucocorticoid receptors in cultured cells. Investigations with a monospecific antiserum against a bacterially expressed receptor fragment. J Biol Chem 264 (1989) 14396-14402
22. Wang X., Pongrac J.L., and DeFranco D.B. Glucocorticoid receptors in hippocampal neurons that do not engage proteasomes escape from hormone-dependent down-regulation but maintain transactivation activity. Mol Endocrinol 16 (2002) 1987-1998
23. Franchimont D., Martens H., Hagelstein M.T., Louis E., Dewe W., Chrousos G.P., et al. Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor. J Clin Endocrinol Metab 84 (1999) 2834-2839
24. Ahmad S., Karlstad M.D., Choudhry M.A., and Sayeed M.M. Sepsis-induced myofibrillar protein catabolism in rat skeletal muscle. Life Sci 55 (1994) 1383-1391
25. Wallace A.D., and Cidlowski J.A. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. J Biol Chem 276 (2001) 42714-42721
26. Kang Z., Pirskanen A., Janne O.A., and Palvimo J.J. Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex. J Biol Chem 277 (2002) 48366-48371
27. Lonard D.M., Nawaz Z., Smith C.L., and O'Malley B.W. The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation. Mol Cell 5 (2000) 939-948
28. Shao W., Keeton E.K., McDonnell D.P., and Brown M. Coactivator AIB1 links estrogen receptor transcriptional activity and stability. Proc Natl Acad Sci USA 101 (2004) 11599-11604
29. Szatmary Z., Garabedian M.J., and Vilcek J. Inhibition of glucocorticoid receptor-mediated transcriptional activation by p38 mitogen-activated protein (MAP) kinase. J Biol Chem 279 (2004) 43708-43715
30. Almawi W.Y., and Melemedjian O.K. Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor. J Leukoc Biol 71 (2002) 9-15
31. Marik P.E. Nuclear factor-kappa B inhibition in sepsis: steroids versus specific nuclear factor-kappa B inhibitors?. Crit Care Med 30 (2002) 2393-2394
32. Chamberlain J.S. Cachexia in cancer-zeroing in on myosin. N Engl J Med 351 (2004) 2124-2125
33. Hermoso M.A., Matsuguchi T., Smoak K., and Cidlowski J.A. Glucocorticoids and tumor necrosis factor alpha cooperatively regulate toll-like receptor 2 gene expression. Mol Cell Biol 24 (2004) 4743-4756
34. Li Y.P., Lecker S.H., Chen Y., Waddell I.D., Goldberg A.L., and Reid M.B. TNF-alpha increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k. FASEB J 17 (2003) 1048-1057
35. Sandri M., Sandri C., Gilbert A., Skurk C., Calabria E., Picard A., et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117 (2004) 399-412